Insider Transactions in Q3 2024 at Pulse Biosciences, Inc. (PLSE)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 24
2024
|
Mitchell E. Levinson Chief Strategy Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
2,206
+4.14%
|
$24,266
$11.0 P/Share
|
|
Sep 24
2024
|
Mitchell E. Levinson Chief Strategy Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
3,000
+3.1%
|
$33,000
$11.0 P/Share
|
|
Jul 19
2024
|
Burke Thomas Barrett |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
1,086
+4.37%
|
$11,946
$11.0 P/Share
|
|
Jul 03
2024
|
Maky Zanganeh Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
60,242
+8.3%
|
-
|
|
Jul 03
2024
|
Robert W Duggan |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
118,332
+10.95%
|
-
|
|
Jul 03
2024
|
Robert W Duggan |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
5,187,824
+10.95%
|
-
|
|
Jul 03
2024
|
Kevin Patrick Danahy Chief Commercial Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
650
+1.75%
|
-
|
|
Jul 03
2024
|
Mitchell E. Levinson Chief Strategy Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
2,207
+4.33%
|
-
|
|
Jul 03
2024
|
Mitchell E. Levinson Chief Strategy Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
3,000
+3.2%
|
-
|
|
Jul 03
2024
|
Burke Thomas Barrett |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
1,086
+8.92%
|
-
|